view more

Company Building, Business Development, Fundraising and Consulting with a Global Perspective

Biotech  -  Pharma  -  Medtech
What we can do for you
 

Consulting Services

We provide experience-based consulting services for Biotech, Pharma and Medtech clients globally. Technical consulting, project management, strategy and management consulting, market and opportunity analyses are some of our core areas of expertise.

go

Company Creation

Ventac Partners has a global network of Life Science investors in Europe, US and Asia as well as expertise in founding and growing companies on behalf of clients. Unlike other consulting agencies, we also found, actively manage, grow and help exit innovative Portfolio Companies co-owned with partners & investors.

go

Corporate Development

We offer extensive buy and sell-side transaction experience with a truly international reach in virtually all Life Science sectors. Our specialties include in- and out-licensing, mergers & acquisitions, business development and marketing collaborations in all continents.

go
  • 03.2017

    Idogen AB, a Ventac portfolio company, announces allowance/grant of a patent application, covering the company’s tolerogenic vaccine technology in Japan, Europe and the US. For more information, please follow this link.

  • 02.2017

    Ventac Partners invest in Neuroscience Technologies to acquire significant co-ownership, and has deployed its international team to the company to grow the business. Neuroscience Technologies is a global leader in human pain neurophysiology. Employing microneurography technology developed over the last decade, Neuroscience Technologies has successfully provided services to the pharmaceutical industry with pre-clinical and clinical services in neuropathic pain and other peripheral nervous disorders quantifying spontaneous activity in pain fibers. For more information on Neuroscience Technologies, visit www.nsc-tec.com.

  • 03.2017

    Ventac portfolio companies, APIM Therapeutics and Avexxin, will be participating at BioEurope Spring Partnering meeting, in Barcelona, Spain (March 20-22, 2017).

  • 01.2017

    Ventac Partners Melya Hughes Crameri will be attending the J.P. Morgan 35th Annual Healthcare Conference 2017 in San Francisco (January 9-13)

  • 01.2017

    Ventac Partners Mikael Oerum and Scott Woodward will be attending the Biotech Showcase conference in San Francisco, California (January 9-11)

Subscribe to our Newsletter

Thank you!